Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.63 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 5/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | NPC1 | O15118 | 3/20 | 0.59 |
| ▸ | RAB9A | P51151 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | CA1 | P00915 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | CA9 | Q16790 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.55 |
| ▸ | GRK2 | P25098 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | HTT | P42858 | 3/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29809375 | 1.00 | HDAC1 (0.63) | HDAC1HDAC6LMNAALDH1A1NPC1 | |
| SCHEMBL410860 | 0.86 | LMNA (0.56) | LMNAALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4796769 | 0.85 | ALDH1A1 (0.54) | HDAC1HDAC6LMNAALDH1A1NPC1 | |
| SCHEMBL2491853 | 0.83 | LMNA (0.66) | LMNAALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1284518 | 0.82 | ALDH1A1 (0.64) | HDAC1HDAC6LMNAALDH1A1NPC1 | |
| SCHEMBL28618912 | 0.82 | ALDH1A1 (0.59) | LMNAALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL2708564 | 0.81 | ALDH1A1 (0.58) | HDAC1HDAC6ALDH1A1NPC1RAB9A | |
| SCHEMBL20560335 | 0.81 | NPC1 (0.59) | LMNAALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL31068310 | 0.81 | KIF11 (0.66) | LMNAALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5428786 | 0.81 | KIF11 (0.66) | LMNAALDH1A1NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114544785-B | Flurbiprofen and detection method of impurities thereof | 远大生命科学(鞍山)有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-114544785-A | Method for detecting flurbiprofen and impurities thereof | 远大生命科学(辽宁)有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-114047216-A | Sorafenib tosylate content determination method based on nuclear magnetic resonance quantification technology | 北京绿谱科技有限公司 | 2022-02-15 | — | — | CN | claimed |
| US-20250179059-A1 | ANTICANCER COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-06-05 | — | — | US | disclosed |
| US-20250026766-A1 | Thiazolopyridyl Amide Derivatives as DNA Polymerase Theta Inhibitors | BEIGENE, LTD. (KY) | 2025-01-23 | — | — | US | disclosed |
| US-12162870-B2 | Anticancer compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-12-10 | — | — | US | disclosed |
| US-20240327386-A1 | AHR INHIBITOR, USE THEREOF, AND PREPARATION METHOD THEREFOR | CHONGQING PHARSCIN INNOBIO CO., LTD. (CN) | 2024-10-03 | — | — | US | disclosed |
| CN-114544785-B | Flurbiprofen and detection method of impurities thereof | 远大生命科学(鞍山)有限公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-4351560-A1 | ANTICANCER COMPOUNDS | The Regents of the University of California (US) | 2024-04-17 | — | — | EP | disclosed |
| CN-117794525-A | Anticancer compounds | 加利福尼亚大学董事会 | 2024-03-29 | — | — | CN | disclosed |
| CN-117705852-A | Method for measuring ethyl 2- (4-bromo-3-fluorophenyl) acetate content by nuclear magnetic resonance fluorine spectrum | 南京药石科技股份有限公司 | 2024-03-15 | — | — | CN | disclosed |
| EP-0778264-A1 | Tertiary amines having antimycotic and cholesterol lowering activity | F. HOFFMANN-LA ROCHE AG (CH) | 1997-06-11 | — | — | EP | disclosed |
| US-5539112-A | 5-aminoflavone derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1996-07-23 | — | — | US | disclosed |
| EP-0638566-A1 | 5-Aminoflavone derivatives, their preparation and their use as antibacterial, anti-estrogenic and/or antitumor agent | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1995-02-15 | — | — | EP | disclosed |
| US-5164502-A | Fluorinating agents | DOWELANCO (US) | 1992-11-17 | — | — | US | disclosed |
| US-5116982-A | Fluorination | DOWELANCO (US) | 1992-05-26 | — | — | US | disclosed |
| EP-0470669-A2 | Preparation of fluorophenols, fluorohalophenols, N-acylfluoroanilines, and N-acylfluorohaloanilines | DOWELANCO (US) | 1992-02-12 | — | — | EP | disclosed |
| US-4801408-A | 3-AMINO-4-FLUORO-6-HALOPHENYLTHIOACETIC ACIDS, 5-SUBSTITUTED ACETANILIDES, HERBICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-01-31 | — | — | US | disclosed |
| US-4709049-A | HERBICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-11-24 | — | — | US | disclosed |
| US-4684397-A | HERBICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250179059-A1 | ANTICANCER COMPOUNDS | BET1, BRD4, BICRA | HDAC1 122/4885HDAC6 216/4885LMNA 4337/4885 |
| US-20240327386-A1 | AHR INHIBITOR, USE THEREOF, AND PREPARATION METHOD THEREFOR | AHR, ARNT, AIPL1 | HDAC1 1321/4885HDAC6 1066/4885LMNA 3754/4885 |
| US-20250026766-A1 | Thiazolopyridyl Amide Derivatives as DNA Polymerase Theta Inhibitors | POLQ, POLK, POLI | HDAC1 219/4885HDAC6 495/4885LMNA 2654/4885 |
| US-12162870-B2 | Anticancer compounds | BET1, BRD4, BICRA | HDAC1 122/4885HDAC6 216/4885LMNA 4337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.